There was considerable variability in the levels of growth hormone in the cancer patients (median=0.9, IQR=0.3–3.0 μg l−1); however, all values were within expected daily variation of this hormone and no patients had levels elevated above normal values (>24 μg l−1). This evidence concerns the gene GH1 and cancer.